EMB
ABBV icon

Elefante Mark B’s AbbVie ABBV Stock Holding History

Elefante Mark B’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Hold
4,590
– – 0.5% 34
2026
Q1 		$998K Buy
4,590
+250
+6% +$55.5K 0.55% 35
2025
Q4 		$992K Buy
4,340
+850
+24% +$194K 0.61% 34
2025
Q3 		$808K Hold
3,490
– – 0.52% 37
2025
Q2 		$648K Sell
3,490
-100
-3% -$18.6K 0.49% 38
2025
Q1 		$752K Hold
3,590
– – 0.6% 33
2024
Q4 		$638K Buy
+3,590
New +$660K 0.58% 33

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Elefante Mark B's ABBV Position: Q2 2026 in Review

Elefante Mark B held its AbbVie (ABBV) position steady in Q2 2026 at 4,590 shares worth $1.16M. The position accounts for 0.5% of the portfolio, ranked #34.

Elefante Mark B first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Elefante Mark B held 4,590 shares of AbbVie worth $1.16M as of Q2 2026.
  • Elefante Mark B left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.5% of Elefante Mark B's portfolio in Q2 2026, its #34 holding.
  • Elefante Mark B first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Elefante Mark B's 13F filing for Q2 2026, filed 13 Aug 2026.